HI
GILD icon

Handelsinvest Investeringsforvaltning’s Gilead Sciences GILD Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,023
Closed -$137K – 119
2019
Q2 		$137K Sell
2,023
-1,977
-49% -$130K 0.03% 118
2019
Q1 		$260K Buy
+4,000
New +$266K 0.06% 108

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's GILD Position: Q3 2019 in Review

Handelsinvest Investeringsforvaltning sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 2,023 shares — an estimated $137K sold.

Handelsinvest Investeringsforvaltning first reported a position in GILD in Q1 2019 and held it in 2 quarters. The position peaked at $260K in Q1 2019. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Handelsinvest Investeringsforvaltning reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • Handelsinvest Investeringsforvaltning sold 2,023 Gilead Sciences shares in Q3 2019, an estimated $137K.
  • Handelsinvest Investeringsforvaltning first reported a position in Gilead Sciences in Q1 2019 and held it in 2 quarters.
  • Handelsinvest Investeringsforvaltning's Gilead Sciences position peaked at $260K in Q1 2019.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q3 2019, filed 22 Oct 2019.